FDA clears Toshiba's Asteion CT scanner

Article

A new CT scanner from Toshiba America Medical Systems has received 510(k) clearance from the Food and Drug Administration. The system, called Asteion, is a subsecond scanner, and Toshiba has positioned it just below the Tustin, CA, vendor's new Aquilion

A new CT scanner from Toshiba America Medical Systems has received 510(k) clearance from the Food and Drug Administration. The system, called Asteion, is a subsecond scanner, and Toshiba has positioned it just below the Tustin, CA, vendor's new Aquilion half-second CT unit (SCAN 9/16/98). Toshiba will introduce Asteion at the upcoming Radiological Society of North America meeting.

Asteion features a 0.75-second rotation speed and solid-state detectors, according to Charles Corogenes, director of the CT business unit at TAMS. The system will carry a 4-million-heat-unit HeliCool x-ray tube and a 48-kW generator. It has a similar graphical user interface to the Aquilion scanner. It will also come standard with Aspire CI, Toshiba's CT fluoroscopy package. Asteion shipments will begin in January, Corogenes said.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.